NCT04852419View on ClinicalTrials.gov

A PHASE 1B STUDY OF ZN-C5 IN CHINESE SUBJECTS

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

May 31, 2021

Primary Completion Date

June 23, 2022

Study Completion Date

June 23, 2022

Conditions

Breast Neoplasms

Interventions

DRUG

ZN-c5

ZN-c5

Trial Locations (1)

Unknown

Fudan University Cancer Hospital, Shanghai

All Listed Sponsors

lead

Zentera Therapeutics HK Limited

INDUSTRY